• Cancer-Selective Action – PNC27 is a synthetic peptide designed to target cancer cells by binding to HDM-2 proteins on their membranes, leading to pore formation.

• Direct Cytotoxicity – Induces necrosis in cancer cells without affecting normal, healthy cells in experimental models.

• Broad Applications – Studied across various cancers, including leukemia, pancreatic, breast, and melanoma.

• Mechanism of Action – Functions by disrupting the cell membrane, triggering cancer cell death rapidly and selectively.

• Potential as Adjunct – Considered for use alongside conventional therapies due to its tumor-specific targeting ability.

• Experimental Status – Currently in early research stages with in vitro and animal studies showing promise.

For research use only (RUO). By purchasing this product, you agree to comply with all stated Terms & Conditions. Store at –20 °C (preferred) or 2–8 °C, protected from light and moisture. Store at 2–8 °C; stable for up to 2–4 weeks